BMO Capital Markets started coverage on shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) in a report published on Monday morning. The brokerage issued an outperform rating on the stock.

Several other equities research analysts have also recently issued reports on ACHC. Jefferies Group LLC set a $60.00 target price on shares of Acadia Healthcare and gave the stock a buy rating in a research report on Wednesday, October 11th. Craig Hallum reissued a buy rating and issued a $65.00 target price (up from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. Zacks Investment Research cut shares of Acadia Healthcare from a buy rating to a hold rating in a research report on Tuesday, August 1st. UBS AG restated a positive rating and issued a $60.00 price target (up previously from $54.00) on shares of Acadia Healthcare in a report on Monday, July 31st. Finally, BidaskClub lowered shares of Acadia Healthcare from a hold rating to a sell rating in a report on Friday, August 18th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Acadia Healthcare has a consensus rating of Buy and a consensus target price of $57.40.

Shares of Acadia Healthcare (NASDAQ:ACHC) opened at 41.56 on Monday. The stock has a market capitalization of $3.65 billion, a P/E ratio of 456.70 and a beta of 1.07. The stock has a 50 day moving average of $46.12 and a 200-day moving average of $46.36. Acadia Healthcare has a 1-year low of $32.54 and a 1-year high of $54.34.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.01. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business had revenue of $715.90 million for the quarter, compared to analysts’ expectations of $717.38 million. During the same period last year, the company earned $0.73 earnings per share. The company’s quarterly revenue was down 5.4% on a year-over-year basis. Equities research analysts predict that Acadia Healthcare will post $2.45 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This report was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was stolen and republished in violation of international copyright & trademark laws. The original version of this report can be viewed at https://www.watchlistnews.com/acadia-healthcare-company-inc-achc-coverage-initiated-by-analysts-at-bmo-capital-markets/1636281.html.

In other Acadia Healthcare news, insider Scott Schwieger sold 2,891 shares of the stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $52.85, for a total value of $152,789.35. Following the transaction, the insider now owns 8,841 shares of the company’s stock, valued at $467,246.85. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Christopher L. Howard sold 53,713 shares of the stock in a transaction dated Tuesday, August 22nd. The shares were sold at an average price of $50.69, for a total value of $2,722,711.97. Following the completion of the transaction, the executive vice president now directly owns 147,286 shares in the company, valued at approximately $7,465,927.34. The disclosure for this sale can be found here. In the last quarter, insiders sold 3,085,693 shares of company stock worth $157,729,099. 11.10% of the stock is owned by company insiders.

Large investors have recently added to or reduced their stakes in the business. BNP Paribas Arbitrage SA lifted its stake in Acadia Healthcare by 2,358.9% in the second quarter. BNP Paribas Arbitrage SA now owns 28,843 shares of the company’s stock valued at $1,424,000 after buying an additional 27,670 shares during the period. Oak Ridge Investments LLC lifted its stake in Acadia Healthcare by 2.8% in the second quarter. Oak Ridge Investments LLC now owns 951,981 shares of the company’s stock valued at $47,009,000 after buying an additional 26,043 shares during the period. Mutual of America Capital Management LLC lifted its stake in Acadia Healthcare by 47.8% in the second quarter. Mutual of America Capital Management LLC now owns 409,179 shares of the company’s stock valued at $20,205,000 after buying an additional 132,356 shares during the period. American Century Companies Inc. lifted its stake in Acadia Healthcare by 5.3% in the second quarter. American Century Companies Inc. now owns 130,941 shares of the company’s stock valued at $6,466,000 after buying an additional 6,553 shares during the period. Finally, AGF Investments Inc. acquired a new position in Acadia Healthcare in the second quarter valued at about $4,941,000.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.